Original Research

Published on 25 Sep 2023

Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model

Dalton T. McLean
Jennifer J. Meudt
Loren D. Lopez Rivera
Dominic T. Schomberg
Derek M. Pavelec
Tyler T. Duellman
Darya G. Buehler
Patrick B. Schwartz
Melissa Graham
Laura M. Lee

Frontiers in Oncology

doi 10.3389/fonc.2023.1253659

262 views

Systematic Review

Published on 25 Sep 2023

The efficacy and safety of different systemic combination therapies on advanced hepatocellular carcinoma: a systematic review and meta-analysis

Ping Li
Ming Hu
Mei Liu
Xiangyu Ren
Donghong Liu
Jiluo Liu
Jianhua Yin
Xiaojie Tan
Guangwen Cao

Frontiers in Oncology

doi 10.3389/fonc.2023.1197782

243 views

Original Research

Published on 25 Sep 2023

Revolutionizing anti-cancer drug discovery against breast cancer and lung cancer by modification of natural genistein: an advanced computational and drug design approach

Shopnil Akash
Shabana Bibi
Partha Biswas
Nobendu Mukerjee
Dhrubo Ahmed Khan
Md. Nazmul Hasan
Nazneen Ahmeda Sultana
Md. Eram Hosen
Yousef A. Bin Jardan
Hiba-Allah Nafidi

Frontiers in Oncology

doi 10.3389/fonc.2023.1228865

323 views

Original Research

Published on 22 Sep 2023

Development, quality, and influencing factors of colonoscopy in China: results from the national census in 2013 and 2020

Yun-Fei Jiao
Zhi-Yuan Cheng
Ye Gao
Chu-Ting Yu
Hui-Shan Jiang
Ting-Lu Wang
Ying Deng
Han Lin
Tian-Jiao Wang
Wei Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1276520

556 views

Retraction

Accepted on 19 Sep 2023

Retraction: AnnexinA5 Might Suppress the Phynotype of Human Gastric Cancer Cells via ERK pathway Author: Frontiers Editorial Office*

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2023.1294881

Case Report

Published on 19 Sep 2023

The novel EGFR mutations (p.E746_S752delinsI, p.T751_I759delinsG, p.L747_S752delinsAA) in patients with non-small cell lung cancer and the clinical treatment strategy: three case reports

Yamin Meng
Xiaodong Li
Lei Zhang
Minhua Ye

Frontiers in Oncology

doi 10.3389/fonc.2023.1129629

290 views

Review

Accepted on 18 Sep 2023

Precision Strikes: PSMA-targeted radionuclide therapy in prostate cancera narrative review Radionuclide-based therapy of prostate cancer focused on the PSMA target

Paweł Szponar
Piotr Igor Petrasz
Katarzyna Brzeźniakiewicz-Janus
Tomasz Drewa
Piotr Zorga
Jan Adamowicz

Frontiers in Oncology

doi 10.3389/fonc.2023.1239118

Mini Review

Published on 15 Sep 2023

Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice

Chenyu Ma
Yuexinzi Jin
Yuhan Wang
Huaguo Xu
Jiexin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1231420

476 views

Original Research

Published on 14 Sep 2023

LTe2 induces cell apoptosis in multiple myeloma by suppressing AKT phosphorylation at Thr308 and Ser473

Yuanjiao Zhang
Jiacheng Qian
Mingmei Jiang
Shu Yang
Lianxin Zhou
Qin Zhang
Liping Lin
Ye Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1269670

333 views

Hypothesis and Theory

Published on 14 Sep 2023

Opioids and immune checkpoint inhibitors differentially regulate a common immune network in triple-negative breast cancer

Joseph R. Scarpa
Giacomo Montagna
George Plitas
Amitabh Gulati
Gregory W. Fischer
Joshua S. Mincer

Frontiers in Oncology

doi 10.3389/fonc.2023.1267532

405 views

Original Research

Published on 13 Sep 2023

System analysis based on the lysosome-related genes identifies HPS4 as a novel therapy target for liver hepatocellular carcinoma

Ke‐Jie He
Zhiqiang Nie

Frontiers in Oncology

doi 10.3389/fonc.2023.1221498

367 views

Review

Published on 12 Sep 2023

Cellular senescence: a double-edged sword in cancer therapy

Shuai Xiao
Dongmin Qin
Xueyang Hou
Lingli Tian
Yeping Yu
Rui Zhang
Hao Lyu
Dong Guo
Xing-Zhen Chen
Cefan Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.1189015

477 views

Review

Accepted on 11 Sep 2023

Use and accuracy of decision support systems using artificial intelligence for tumor diseases: A systematic review and meta-analysis

Robert Oehring
Nikitha Ramasetti
Sharlyn Ng
Roland Roller
Philippe Thomas
Axel Winter
Max Maurer
Simon Moosburner
Nathanael Raschzok
Can Kamali

Frontiers in Oncology

doi 10.3389/fonc.2023.1224347

Case Report

Accepted on 11 Sep 2023

Case Report:Ensartinib for gastric epithelioid inflammatory myofibrosarcoma with STRN-ALK fusion

Zhong Lu
Xiaoqing Li
Jingfan Zheng
Xinyi Li
Yuyu Chen
Kang Liu
Fangchao Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1252221

Review

Published on 08 Sep 2023

Single domain Camelid antibody fragments for molecular imaging and therapy of cancer

Shulin Li
Sanne Johanna Maria Hoefnagel
Kausilia Krishnawatie Krishnadath

Frontiers in Oncology

doi 10.3389/fonc.2023.1257175

524 views

Original Research

Published on 08 Sep 2023

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma

Kristina Breitenecker
Viola Hedrich
Franziska Pupp
Doris Chen
Eva Řezníčková
Gregor Ortmayr
Heidemarie Huber
Gerhard Weber
Lorenz Balcar
Matthias Pinter

Frontiers in Oncology

doi 10.3389/fonc.2023.1238883

485 views

Navigation group

Articles

Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model

The efficacy and safety of different systemic combination therapies on advanced hepatocellular carcinoma: a systematic review and meta-analysis

Revolutionizing anti-cancer drug discovery against breast cancer and lung cancer by modification of natural genistein: an advanced computational and drug design approach

Development, quality, and influencing factors of colonoscopy in China: results from the national census in 2013 and 2020

Retraction: AnnexinA5 Might Suppress the Phynotype of Human Gastric Cancer Cells via ERK pathway Author: Frontiers Editorial Office*

The novel EGFR mutations (p.E746_S752delinsI, p.T751_I759delinsG, p.L747_S752delinsAA) in patients with non-small cell lung cancer and the clinical treatment strategy: three case reports

Precision Strikes: PSMA-targeted radionuclide therapy in prostate cancera narrative review Radionuclide-based therapy of prostate cancer focused on the PSMA target

Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice

LTe2 induces cell apoptosis in multiple myeloma by suppressing AKT phosphorylation at Thr308 and Ser473

Opioids and immune checkpoint inhibitors differentially regulate a common immune network in triple-negative breast cancer

System analysis based on the lysosome-related genes identifies HPS4 as a novel therapy target for liver hepatocellular carcinoma

Cellular senescence: a double-edged sword in cancer therapy

Use and accuracy of decision support systems using artificial intelligence for tumor diseases: A systematic review and meta-analysis

Case Report:Ensartinib for gastric epithelioid inflammatory myofibrosarcoma with STRN-ALK fusion

Single domain Camelid antibody fragments for molecular imaging and therapy of cancer

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma